CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Horizon Discovery Group PLC Company Snapshot
Horizon Discovery Group PLC operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Horizon Discovery Group PLC with three other pharmaceutical manufacturers in Europe: Eczacibasi Ilac Sanayi ve T.A.S. of Turkey (2018 sales of 692.09 million Turkish Liras [US$118.12 million] of which 80% was Health), New Nordic Healthbrands AB of Sweden (393.71 million Swedish Kronor [US$40.13 million] ), and Moberg Pharma AB (publ) which is also based in Sweden (439.04 million Swedish Kronor [US$44.75 million] of which 40% was Kerasal Nail /Nalox).

Sales Analysis. Horizon Discovery Group PLC reported sales of £58.73 million (US$74.35 million) for the year ending December of 2018. This represents an increase of 60.9% versus 2017, when the company's sales were £36.51 million. Sales at Horizon Discovery Group PLC have increased during each of the previous five years (and since 2013, sales have increased a total of 784%). Sales of Products saw an increase of 102.8% in 2018, from £22.82 million to £46.28 million. Not all segments of Horizon Discovery Group PLC experienced an increase in sales in 2018: sales of Services fell 20.6% to £10.87 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Horizon Discovery Group PLC
  Stock Performance Chart for Horizon Discovery Group PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 159.70p
(Figures in Pounds Sterling)
1 Week 5.5%   13 Weeks 15.7%  
4 Weeks -3.1%   52 Weeks -23.6%  
 
Horizon Discovery Group PLC Key Data:
  Ticker: HZD Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2018 Sales 58,733,000
(Year Ending Jan 2019).
Employees: 398
  Currency: Pounds Sterling Market Cap: 240,248,079
  Fiscal Yr Ends: December Shares Outstanding: 150,437,119
  Share Type: Ordinary Closely Held Shares: 13,534,991
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.